Comparative Benchmarking
In the context of the broader market, INKT competes directly with industry leaders such as HYFT and SGMO. With a market capitalization of $52.36M, it holds a significant position in the sector. When comparing efficiency, INKT's gross margin of N/A stands against HYFT's 59.26% and SGMO's N/A. Such benchmarking helps identify whether Mink Therapeutics Inc is trading at a premium or discount relative to its financial performance.
